ClinicalTrials.Veeva

Menu

Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.

M

mona nematallah

Status

Unknown

Conditions

Preterm Labor

Treatments

Diagnostic Test: serum amyloid a test

Study type

Observational

Funder types

Other

Identifiers

NCT03205020
amyloid a

Details and patient eligibility

About

The aim of the current study is to assess the accuracy of maternal serum amyloid A for prediction of preterm labor in women with threatened preterm labor.

Enrollment

58 estimated patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant women, age 18 - 35.
  • Gestational age: 28 - 36+6 weeks.
  • Singleton pregnancy.
  • No past history of any medical disorder and with no other medical complications during pregnancy
  • Nonsmoker.
  • Diagnosis of preterm labor is based on the American College of Obstetricians and Gynecologists Guidelines

Criteria of preterm delivery:

  1. Gestational age: 28 - 36+6 weeks
  2. Presence of uterine contractions (at least 4 in 20 minutes or 8 in 60 minutes)
  3. cervical dilation ≥ 4 cm
  4. Cervical effacement ≥ 80%.

Exclusion criteria

  • Of any patient with the following risk factors for preterm labor:

    • Over distended uterus .
    • hemorrhage
    • Uterine anomalies

Trial design

58 participants in 2 patient groups

women with preterm labor
Treatment:
Diagnostic Test: serum amyloid a test
women delivered at full term
Treatment:
Diagnostic Test: serum amyloid a test

Trial contacts and locations

1

Loading...

Central trial contact

MONA M, MS; mona cairo nematallah, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems